Brookdale (NYSE:BKD) Reports Q1 In Line With Expectations But Stock Drops

BKD Cover Image — Brookdale (NYSE:BKD) Reports Q1 In Line With Expectations But Stock Drops

Petr Huřťák

Tue, May 6, 2025, 2:32 PM 5 min read

Revenue: $813.9 million vs analyst estimates of $816.9 million (4% year-on-year growth, in line)
EPS (GAAP): -$0.28 vs analyst estimates of -$0.11 (significant miss)
Adjusted EBITDA: $124.1 million vs analyst estimates of $112.8 million (15.3% margin, 10% beat)
EBITDA guidance for the full year is $445 million at the midpoint, above analyst estimates of $440.4 million
Operating Margin: 3.6%, in line with the same quarter last year
Free Cash Flow was -$18.42 million compared to -$45.55 million in the same quarter last year
Market Capitalization: $1.33 billion

Company Overview

With a network of over 650 communities serving approximately 59,000 residents across 41 states, Brookdale Senior Living (NYSE:BKD) operates senior living communities across the United States, offering independent living, assisted living, memory care, and continuing care retirement communities.

Sales Growth

A company’s long-term performance is an indicator of its overall quality. Even a bad business can shine for one or two quarters, but a top-tier one grows for years. Brookdale struggled to consistently generate demand over the last five years as its sales dropped at a 4.8% annual rate. This wasn’t a great result and is a sign of poor business quality.

Long-term growth is the most important, but within healthcare, a half-decade historical view may miss new innovations or demand cycles. Brookdale’s annualized revenue growth of 4.3% over the last two years is above its five-year trend, but we were still disappointed by the results.

We can dig further into the company’s revenue dynamics by analyzing its most important segment, . Over the last two years, Brookdale’s revenue averaged 6.3% year-on-year growth. This segment has outperformed its total sales during the same period, lifting the company’s performance.

This quarter, Brookdale grew its revenue by 4% year on year, and its $813.9 million of revenue was in line with Wall Street’s estimates.

Looking ahead, sell-side analysts expect revenue to remain flat over the next 12 months, a deceleration versus the last two years. This projection doesn't excite us and indicates its products and services will face some demand challenges.

Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we’ve identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.

Operating Margin

Although Brookdale was profitable this quarter from an operational perspective, it’s generally struggled over a longer time period. Its expensive cost structure has contributed to an average operating margin of negative 1% over the last five years. Unprofitable healthcare companies require extra attention because they could get caught swimming naked when the tide goes out. It’s hard to trust that the business can endure a full cycle.

On the plus side, Brookdale’s operating margin rose by 6.6 percentage points over the last five years. This performance was mostly driven by its past improvements as the company’s margin was relatively unchanged on two-year basis.

Brookdale Trailing 12-Month Operating Margin (GAAP)

In Q1, Brookdale generated an operating profit margin of 3.6%, in line with the same quarter last year. This indicates the company’s overall cost structure has been relatively stable.

Earnings Per Share

Revenue trends explain a company’s historical growth, but the long-term change in earnings per share (EPS) points to the profitability of that growth – for example, a company could inflate its sales through excessive spending on advertising and promotions.

Sadly for Brookdale, its EPS declined by 27.1% annually over the last five years, more than its revenue. However, its operating margin actually expanded during this time, telling us that non-fundamental factors such as interest expenses and taxes affected its ultimate earnings.

We can take a deeper look into Brookdale’s earnings to better understand the drivers of its performance. A five-year view shows Brookdale has diluted its shareholders, growing its share count by 25%. This dilution overshadowed its increased operating efficiency and has led to lower per share earnings. Taxes and interest expenses can also affect EPS but don’t tell us as much about a company’s fundamentals.

In Q1, Brookdale reported EPS at negative $0.28, down from negative $0.13 in the same quarter last year. This print missed analysts’ estimates. Over the next 12 months, Wall Street expects Brookdale to improve its earnings losses. Analysts forecast its full-year EPS of negative $1.03 will advance to negative $0.51.

Key Takeaways from Brookdale’s Q1 Results

It was good to see Brookdale provide full-year EBITDA guidance that slightly beat analysts’ expectations. On the other hand, its EPS missed significantly and its revenue was in line with Wall Street’s estimates. Overall, this was a softer quarter. The stock traded down 5.4% to $6.42 immediately following the results.

Brookdale’s earnings report left more to be desired. Let’s look forward to see if this quarter has created an opportunity to buy the stock. When making that decision, it’s important to consider its valuation, business qualities, as well as what has happened in the latest quarter. We cover that in our actionable full research report which you can read here, it’s free.

Terms and Privacy Policy

Your Privacy Choices

Utah Privacy Notice

More Info